Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (481-490 of 740) with videos related to

Pageof 74
Sort By:
Msphere|June 23, 2021
Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting ColonizationKrishna Rao, Alieysa Patel, Yuang Sun, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
<i>In Vitro</i> Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeDennis Huang, Brenda Yu, John K Diep, et al.
American Journal of Infection Control|May 16, 2017
Bathing hospitalized dependent patients with prepackaged disposable washcloths instead of traditional bath basins: A case-crossover studyEmily Toth Martin, Samran Haider, Maria Palleschi, et al.
Contemporary Clinical Trials Communications|December 16, 2025
Impact of updated regulatory guidelines on study results in contemporary uncomplicated urinary tract infection clinical trials and implications for trial conduct and drug development: a comparative analysis with EAGLE-2 and EAGLE-3Florian Wagenlehner, Keith S Kaye, David A Talan, et al.
Journal of Clinical Microbiology|May 23, 1998
Comparison of culture- and non-culture-based methods for quantification of viral load and resistance to antiretroviral drugs in patients given zidovudine monotherapyR S Tedder, S Kaye, C Loveday, et al.
Open Forum Infectious Diseases|April 17, 2023
Risk Factors Associated With Antimicrobial Resistance and Adverse Short-Term Health Outcomes Among Adult and Adolescent Female Outpatients With Uncomplicated Urinary Tract InfectionBarbara W Trautner, Keith S Kaye, Vikas Gupta, et al.
American Journal of Infection Control|September 4, 2012
The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patientsEmily T Martin, Ryan Tansek, Vicki Collins, et al.
Journal of Neurotrauma|September 10, 2011
Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-APhilippe M D'Onofrio, Mahinthan Thayapararajah, Meghan D Lysko, et al.
Journal of Clinical Microbiology|December 1, 1996
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasmaR Schuurman, D Descamps, G J Weverling, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancerP A Vasey, R Atkinson, R Osborne, et al.
Pageof 74

Showing results (481-490 of 740) with videos related to

Sort By:
Pageof 74
Msphere|June 23, 2021
Risk Factors for Klebsiella Infections among Hospitalized Patients with Preexisting ColonizationKrishna Rao, Alieysa Patel, Yuang Sun, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
<i>In Vitro</i> Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeDennis Huang, Brenda Yu, John K Diep, et al.
American Journal of Infection Control|May 16, 2017
Bathing hospitalized dependent patients with prepackaged disposable washcloths instead of traditional bath basins: A case-crossover studyEmily Toth Martin, Samran Haider, Maria Palleschi, et al.
Contemporary Clinical Trials Communications|December 16, 2025
Impact of updated regulatory guidelines on study results in contemporary uncomplicated urinary tract infection clinical trials and implications for trial conduct and drug development: a comparative analysis with EAGLE-2 and EAGLE-3Florian Wagenlehner, Keith S Kaye, David A Talan, et al.
Journal of Clinical Microbiology|May 23, 1998
Comparison of culture- and non-culture-based methods for quantification of viral load and resistance to antiretroviral drugs in patients given zidovudine monotherapyR S Tedder, S Kaye, C Loveday, et al.
Open Forum Infectious Diseases|April 17, 2023
Risk Factors Associated With Antimicrobial Resistance and Adverse Short-Term Health Outcomes Among Adult and Adolescent Female Outpatients With Uncomplicated Urinary Tract InfectionBarbara W Trautner, Keith S Kaye, Vikas Gupta, et al.
American Journal of Infection Control|September 4, 2012
The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patientsEmily T Martin, Ryan Tansek, Vicki Collins, et al.
Journal of Neurotrauma|September 10, 2011
Gene therapy for traumatic central nervous system injury and stroke using an engineered zinc finger protein that upregulates VEGF-APhilippe M D'Onofrio, Mahinthan Thayapararajah, Meghan D Lysko, et al.
Journal of Clinical Microbiology|December 1, 1996
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasmaR Schuurman, D Descamps, G J Weverling, et al.
British Journal of Cancer|January 13, 2006
SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancerP A Vasey, R Atkinson, R Osborne, et al.
Pageof 74